Dapagliflozin and Apparent Treatment-Resistant Hypertension in Heart Failure With Mildly Reduced or Preserved Ejection Fraction: The DELIVER Trial - Ostrominski, J W; Vaduganathan, M; Selvaraj, S (Circulation, 2023)
et al.